Astrana Health, Inc. ASTH
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $3.2B | +56% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $1.4M | -4% | FY ending Jan 31, 2014 |
| Operating income | $78.5M | -12% | FY ending Dec 31, 2025 |
| Net income | $22.5M | -48% | FY ending Dec 31, 2025 |
| Earnings per share | $0.46 | -49% | FY ending Dec 31, 2025 |
| Cash from operations | $114.6M | +120% | FY ending Dec 31, 2025 |
| Capital spending | $10.1M | +26% | FY ending Dec 31, 2025 |
| Share buybacks | $25.6M | +2744% | FY ending Dec 31, 2025 |
| Dividends paid | $7.9M | +95% | FY ending Dec 31, 2025 |
| Cash | $429.5M | +49% | FY ending Dec 31, 2025 |
| Long-term debt | $990.9M | +133% | FY ending Dec 31, 2025 |
| Shareholders' equity | $779.3M | +9% | FY ending Dec 31, 2025 |
| Shares outstanding | 49M | +2% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 0 sales ($0) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
Other insider moves (42): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| John VongSVP - Accounting (PAO) | Tax withholding | 556 | $37.55 | $21K | Oct 10, 2026 |
| Brandon SimCEO and President | Tax withholding | 9,889 | $37.00 | $366K | Oct 6, 2026 |
| Thomas S. LamDirector | Tax withholding | 2,624 | $37.00 | $97K | Oct 6, 2026 |
| Chandan BashoCOO and CFO | Tax withholding | 2,092 | $35.88 | $75K | Oct 2, 2026 |
| John VongSVP - Accounting (PAO) | Tax withholding | 96 | $38.35 | $3,682 | Sep 15, 2026 |
| Brandon SimCEO and President | Tax withholding | 7,163 | $38.47 | $276K | Sep 5, 2026 |
| Chandan BashoCOO and CFO | Tax withholding | 1,790 | $38.47 | $69K | Sep 5, 2026 |
| Mitchell W KitayamaDirector | Returned | 8,500 | $37.09 | $315K | Aug 31, 2026 |
| David SchmidtDirector | Returned | 20,000 | $38.59 | $772K | Aug 14, 2026 |
| David SchmidtDirector | Option exercise | 20,000 | $5.00 | $100K | Aug 14, 2026 |
| Glenn Sobotka | Returned | 11,793 | – | – | Aug 7, 2026 |
| Brandon SimCEO and President | Tax withholding | 1,093 | $44.51 | $49K | Jun 27, 2026 |
| David SchmidtDirector | Award | 4,525 | – | – | Jun 10, 2026 |
| Matthew MazdyasniDirector | Award | 4,525 | – | – | Jun 10, 2026 |
| Mitchell W KitayamaDirector | Award | 4,991 | – | – | Jun 10, 2026 |
| Linda DongDirector | Award | 4,525 | – | – | Jun 10, 2026 |
| Weili Dai,Director | Award | 4,525 | – | – | Jun 10, 2026 |
| John ChiangDirector | Award | 4,525 | – | – | Jun 10, 2026 |
| Chandan BashoCOO and CFO | Tax withholding | 8,155 | $38.26 | $312K | May 16, 2026 |
| Chandan BashoCOO and CFO | Tax withholding | 3,870 | $29.07 | $113K | Apr 14, 2026 |
| Thomas S. LamDirector | Award | 41,667 | – | – | Apr 6, 2026 |
| Kenneth T. SimExecutive Chairman, Director | Award | 100,000 | – | – | Apr 6, 2026 |
| Brandon SimCEO and President | Award | 201,056 | – | – | Apr 6, 2026 |
| Chandan BashoCOO and CFO | Tax withholding | 2,092 | $25.05 | $52K | Apr 2, 2026 |
| Dinesh M. KumarChief Medical Officer | Tax withholding | 57,980 | $24.51 | $1.4M | Apr 1, 2026 |
| Dinesh M. KumarChief Medical Officer | Award | 35,300 | – | – | Apr 1, 2026 |
| Glenn SobotkaChief Accounting Officer | Tax withholding | 662 | $24.27 | $16K | Mar 26, 2026 |
| Thomas S. LamDirector | Tax withholding | 9,266 | $25.07 | $232K | Mar 5, 2026 |
| Dinesh M. KumarChief Medical Officer | Tax withholding | 1,697 | $25.07 | $43K | Mar 5, 2026 |
| Chandan BashoCOO and CFO | Tax withholding | 1,240 | $25.07 | $31K | Mar 5, 2026 |
| Brandon SimCEO and President | Option exercise | 21,334 | $23.24 | $496K | Feb 2, 2026 |
| Dinesh M. KumarChief Medical Officer | Tax withholding | 10,759 | $27.16 | $292K | Jan 23, 2026 |
| David SchmidtDirector | Option exercise | 20,000 | $5.79 | $116K | Jan 13, 2026 |
| David SchmidtDirector | Tax withholding | 4,269 | $27.12 | $116K | Jan 13, 2026 |
| Dinesh M. KumarChief Medical Officer | Tax withholding | 5,102 | $24.81 | $127K | Jan 1, 2026 |
| Thomas S. LamDirector | Tax withholding | 25,866 | $22.00 | $569K | Dec 8, 2025 |
| Thomas S. LamDirector | Option exercise | 29,502 | $17.78 | $525K | Dec 8, 2025 |
| Kenneth T. SimExecutive Chairman, Director | Option exercise | 29,502 | $17.78 | $525K | Nov 10, 2025 |
| Matthew MazdyasniDirector | Option exercise | 20,000 | $18.20 | $364K | Nov 10, 2025 |
| Mitchell W KitayamaDirector | Option exercise | 12,000 | $18.20 | $218K | Nov 7, 2025 |
| Linda MarshDirector | Option exercise | 20,000 | $18.20 | $364K | Nov 3, 2025 |
| Linda MarshDirector | Tax withholding | 11,033 | $32.99 | $364K | Nov 3, 2025 |
Trades by members of Congress
1 member reported 1 buy and 1 sale since Aug 19, 2025. Amounts are legal ranges, not exact figures.
Latest SEC filings
- News filing: Public announcement (Reg FD) 8-K · Sep 23, 2026
- News filing: Cybersecurity incident 8-K · Sep 23, 2026
- News filing: Public announcement (Reg FD) 8-K · Sep 15, 2026
- Quarterly report 10-Q · Aug 10, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Aug 6, 2026
- News filing: Public announcement (Reg FD) 8-K · Jul 13, 2026
- News filing: Executive or board change 8-K · Jul 1, 2026
- News filing: Executive or board change, Shareholder vote results 8-K · Jun 10, 2026
- News filing: Executive or board change 8-K · May 12, 2026
- News filing: Public announcement (Reg FD) 8-K · May 12, 2026
- Quarterly report 10-Q · May 8, 2026
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · May 7, 2026
- Shareholder meeting proxy DEF 14A · Apr 17, 2026
- News filing: Other news 8-K · Mar 30, 2026
- Annual report 10-K · Mar 12, 2026
- News filing: Public announcement (Reg FD) 8-K · Mar 4, 2026
- News filing: Quarterly results, Public announcement (Reg FD), Other news 8-K · Mar 2, 2026
- News filing: Public announcement (Reg FD) 8-K · Jan 12, 2026
- Quarterly report 10-Q · Nov 10, 2025
- News filing: Quarterly results, Public announcement (Reg FD) 8-K · Nov 6, 2025
- Quarterly report 10-Q · Aug 7, 2025
- News filing: Quarterly results 8-K · Aug 7, 2025
- News filing: Signed a major agreement, Bought or sold a business or assets, Quarterly results, Public announcement (Reg FD) 8-K · Jul 2, 2025
- News filing: Executive or board change, Shareholder vote results 8-K · Jun 11, 2025
- News filing: Public announcement (Reg FD) 8-K · Jun 4, 2025
About Astrana Health, Inc.
Business description
- Industry
- Services-Management Consulting Services
- Sector
- Trade & Services
- Headquarters
- Alhambra, CA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- Formerly
- Apollo Medical Holdings, Inc., SICLONE INDUSTRIES INC
- SEC company number (CIK)
- 1083446
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.